title: Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia.
authors.forename: Despina
authors.initials: D
authors.lastname: Pantelidou
authors.forename: Costas
authors.initials: C
authors.lastname: Tsatalas
authors.forename: Dimitris
authors.initials: D
authors.lastname: Margaritis
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Kaloutsi
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Spanoudakis
authors.forename: George
authors.initials: G
authors.lastname: Bourikas
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000150:complications* / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab